Archive by date | June 20th, 2013

Innovative Financing for Cancer R&D

Innovative Financing for Cancer R&D

Over the past week, we have seen extended press coverage of the principles of a potential cancer ‘megafund,’ building on ideas from the October 2012 Nature Biotechnology article by Fernandez, Stein & Lo on “Commercialization biomedical research through securitization techniques.”  The Economist covered it here and the Financial Times added its commentary here.  Read more